223
Participants
Start Date
June 30, 2010
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
Sarilumab
"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"
Sanofi-Aventis Administrative Office, Bridgewater
Sanofi-Aventis Administrative Office, Macquarie Park
Sanofi-Aventis Administrative Office, Vienna
Sanofi-Aventis Administrative Office, Diegem
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Prague
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Vilnius
Sanofi-Aventis Administrative Office, Gouda
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Barcelona
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY